{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:53:41Z","timestamp":1794009221108,"version":"4.8.0"},"reference-count":148,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cLucian Blaga\u201d University of Sibiu (Knowledge Transfer Center) &amp; Hasso Plattner Foundation","award":["LBUS-HPI-ERG-2023-05"],"award-info":[{"award-number":["LBUS-HPI-ERG-2023-05"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Multiple endocrine neoplasia type 1 (MEN1)-related primary hyperparathyroidism (MPHPT) belongs to genetic PHPT that accounts for 10% of all PHPT cases, being considered the most frequent hereditary PHPT (less than 5% of all PHPT). Objective: We aimed to provide an updated clinical perspective with a double purpose: to highlight the clinical features in MPHPT, particularly, the bone health assessment, as well as the parathyroidectomy (PTx) impact. Methods: A comprehensive review of the latest 5-year, English-published, PubMed-accessed original studies. Results: The sample-based analysis (n = 17 studies) enrolled 2426 subjects (1720 with MPHPT). The study design was retrospective, except for one prospective and one case\u2013control study. The maximum number of patients per study was of 517. Female predominance (an overall female-to-male ratio of 1.139) was confirmed (except for three studies). Age at MPHPT diagnosis (mean\/median per study): 28.7 to 43.1 years; age at PTx: 32 to 43.5 years. Asymptomatic PHPT was reported in 38.3% to 67% of MPHPT. Mean total calcium varied between 1.31 and 2.88 mmol\/L and highest PTH was of 317.2 pg\/mL. Two studies reported similar PTH and calcaemic levels in MPHPT vs. sporadic PHPT, while another found higher values in MPHPT. Symptomatic vs. asymptomatic patients with MPHPT had similar PTH and serum calcium levels (n = 1). Osteoporosis (n = 8, N = 723 with MPHPT) was reported in 10% to 55.5% of cases, osteopenia in 5.88% to 43.9% (per study); overall fracture rate was 10% (of note, one study showed 0%). Lower bone mineral density (BMD) at DXA (n = 4) in MPHPT vs. sporadic PHPT\/controls was found by some studies (n = 3, and only a single study provided third distal radius DXA-BMD assessment), but not all (n = 1). Post-PTx DXA (n = 3, N = 190 with MPHPT) showed a BMD increase (e.g., +8.5% for lumbar spine, +2.1% for total hip, +4.3% for femoral neck BMD); however, post-operatory, BMD remains lower than controls. Trabecular bone score (TBS) analysis (n = 2, N = 142 with MPHPT vs. 397 with sporadic PHPT) showed a higher prevalence of reduced TBS (n = 1) or similar (n = 1). PTx analysis in MPHPT (n = 14): rate of subtotal PTx of 39% to 66.7% (per study) or less than subtotal PTx of 46.9% (n = 1). Post-PTx complications: persistent PHPT (5.6% to 25%), recurrent PHPT (16.87% to 30%, with the highest re-operation rate of 71% in one cohort); hypoparathyroidism (12.4% to 41.7%). Genetic analysis pointed out a higher risk of post-PTx recurrence in exon 10 MEN1 pathogenic variant. Post-PTx histological exam showed a multi-glandular disease in 40% to 52.1% of MPHPT, and a parathyroid carcinoma prevalence of 1%. Conclusions: MPHPT remains a challenging ailment amid a multi-layered genetic syndrome. Current data showed a lower age at MPHPT diagnosis and surgery than found in general population, and a rate of female predominance that is lower than seen in sporadic PHPT cases, but higher than known, for instance, in MEN2. The bone involvement showed heterogeneous results, more consistent for a lower BMD, but not necessarily for a lower TBS vs. controls. PTx involves a rather high rate of recurrence, persistence and redo surgery. About one out of ten patients with MPHPT might have a prevalent fracture and PTx improves the overall bone health, but seems not to restore it to the general population level, despite the young age of the subjects. This suggests that non-parathyroid components and potentially menin protein displays negative bone effects in MEN1.<\/jats:p>","DOI":"10.3390\/jcm14093113","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T09:16:12Z","timestamp":1746090972000},"page":"3113","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An Updated Perspective of the Clinical Features and Parathyroidectomy Impact in Primary Hyperparathyroidism Amid Multiple Endocrine Neoplasia Type 1 (MEN1): Focus on Bone Health"],"prefix":"10.3390","volume":"14","author":[{"given":"Ana-Maria","family":"Gheorghe","sequence":"first","affiliation":[{"name":"PhD Doctoral School, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Stanciu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 550024 Sibiu, Romania"},{"name":"Department of Endocrinology, Clinical County Emergency Hospital, 550245 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3938-705X","authenticated-orcid":false,"given":"Ioana Codruta","family":"Lebada","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 550024 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2274-5666","authenticated-orcid":false,"given":"Claudiu","family":"Nistor","sequence":"additional","affiliation":[{"name":"Department 4-Cardio-Thoracic Pathology, Thoracic Surgery II Discipline, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Thoracic Surgery Department, \u201cDr. Carol Davila\u201d Central Military University Emergency Hospital, 010242 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8585-3835","authenticated-orcid":false,"given":"Mara","family":"Carsote","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Clinical Endocrinology V, \u201cC.I. Parhon\u201d National Institute of Endocrinology, 011863 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pop.2024.03.006","article-title":"Multiple Endocrine Neoplasia Type 1, Type 2A, and Type 2B","volume":"51","author":"Greenberg","year":"2024","journal-title":"Prim. Care"},{"key":"ref_2","first-page":"4","article-title":"Multiple endocrine neoplasia type 1 in patients with gastroenteropancreatic neuroendocrine tumors: An opportunity for early diagnosis and appropriate management","volume":"13","year":"2020","journal-title":"Mol. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.semcancer.2021.04.011","article-title":"Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs)","volume":"79","author":"Effraimidis","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.mce.2017.09.032","article-title":"MENIN loss as a tissue-specific driver of tumorigenesis","volume":"469","author":"Li","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_5","first-page":"527","article-title":"Multiple Endocrine Neoplasia Type 1","volume":"121","author":"Manoharan","year":"2024","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_6","first-page":"348","article-title":"Parathyroidectomy: Is vitamin D a player for a good outcome?","volume":"4","author":"Carsote","year":"2016","journal-title":"J. Med. Life"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.suc.2024.02.010","article-title":"Complex Primary Hyperparathyroidism: Hereditary and Recurrent Disease","volume":"104","author":"Balachandra","year":"2024","journal-title":"Surg. Clin. N. Am."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism","volume":"37","author":"Minisola","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ecl.2021.08.003","article-title":"Hereditary Primary Hyperparathyroidism","volume":"50","author":"Newey","year":"2021","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_10","first-page":"476","article-title":"Metastases in daily endocrine practice","volume":"51","author":"Carsote","year":"2016","journal-title":"Arch. Balk. Med. Union."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"101694","DOI":"10.1016\/j.ando.2025.101694","article-title":"Chapter 5: The roles of genetics in primary hyperparathyroidism","volume":"86","author":"Romanet","year":"2025","journal-title":"Ann. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101695","DOI":"10.1016\/j.ando.2025.101695","article-title":"Chapter 6: Syndromic primary hyperparathyroidism","volume":"86","author":"Haissaguerre","year":"2025","journal-title":"Ann. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MD.0b013e3182954af1","article-title":"Causes of death and prognostic factors in multiple endocrine neoplasia type 1: A prospective study: Comparison of 106 MEN1\/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors","volume":"92","author":"Ito","year":"2013","journal-title":"Medicine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"105129","DOI":"10.1016\/j.jbspin.2021.105129","article-title":"Bone and primary hyperparathyroidism","volume":"89","author":"Cormier","year":"2022","journal-title":"Joint Bone Spine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.2174\/1381612824999201105165642","article-title":"Cardiovascular Risk in Patients with Primary Hyperparathyroidism","volume":"26","author":"Tournis","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101692","DOI":"10.1016\/j.ando.2025.101692","article-title":"Chapter 3: Impact of primary hyperparathyroidism","volume":"86","author":"Scheyer","year":"2025","journal-title":"Ann. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s13304-017-0451-y","article-title":"Surgical approaches in hereditary endocrine tumors","volume":"69","author":"Iacobone","year":"2017","journal-title":"Updates Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101698","DOI":"10.1016\/j.ando.2025.101698","article-title":"Chapter 9: Indications for the treatment of primary hyperparathyroidism","volume":"86","author":"Frey","year":"2025","journal-title":"Ann. Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"101721","DOI":"10.1016\/j.ando.2025.101721","article-title":"Management of primary hyperparathyroidism in MEN1: From initial subtotal surgery to complex treatment of the remaining gland","volume":"86","author":"Schubert","year":"2025","journal-title":"Ann. Endocrinol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13023-020-01380-1","article-title":"Bone tissue and mineral metabolism in hereditary endocrine tumors: Clinical manifestations and genetic bases","volume":"15","author":"Maraghelli","year":"2020","journal-title":"Orphanet. J. Rare Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.6061\/clinics\/2012(Sup01)28","article-title":"Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1","volume":"67","author":"Coutinho","year":"2012","journal-title":"Clinics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10067-020-05281-3","article-title":"Multiple endocrine neoplasia type 1 revealed by a hip pathologic fracture","volume":"40","author":"Slouma","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Eremkina, A.K., Pylina, S.V., Elfimova, A.R., Gorbacheva, A.M., Humbert, L., L\u00f3pez Picazo, M., Hajrieva, A.V., Solodovnikova, E.N., Kovalevich, L.D., and Vetchinkina, E.A. (2024). Analysis of Bone Phenotype Differences in MEN1-Related and Sporadic Primary Hyperparathyroidism Using 3D-DXA. J. Clin. Med., 13.","DOI":"10.3390\/jcm13216382"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"ziae129","DOI":"10.1093\/jbmrpl\/ziae129","article-title":"Bone mineral density over ten years after primary parathyroidectomy in multiple endocrine neoplasia type 1","volume":"8","author":"Kuusela","year":"2024","journal-title":"JBMR Plus"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/SLA.0000000000005980","article-title":"Recurrence After Surgery for Primary Hyperparathyroidism in 517 Patients With Multiple Endocrine Neoplasia Type 1: An Association Francophone de Chirurgie Endocrinienne and Groupe d\u2019\u00e9tude des Tumeurs Endocrines study","volume":"279","author":"Santucci","year":"2024","journal-title":"Ann. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.surg.2023.05.044","article-title":"Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: Impact of genotype and surgical approach on long-term postoperative outcomes","volume":"175","author":"Shariq","year":"2024","journal-title":"Surgery"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s40618-023-02032-4","article-title":"Familial parathyroid tumours-comparison of clinical profiles between syndromes","volume":"46","author":"Figueiredo","year":"2023","journal-title":"J. Endocrinol. Investig."},{"key":"ref_30","first-page":"S423","article-title":"Recurrent Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1 Syndrome","volume":"72","author":"Kushnir","year":"2023","journal-title":"Physiol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/clinem\/dgad460","article-title":"Trabecular Bone Score as a More Sensitive Tool to Evaluate Bone Involvement in MEN1-related Primary Hyperparathyroidism","volume":"109","author":"Song","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e220021","DOI":"10.1530\/EC-22-0021","article-title":"Impact of parathyroidectomy on quality of life in multiple endocrine neoplasia type 1","volume":"11","author":"Brescia","year":"2022","journal-title":"Endocr. Connect."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.surg.2021.10.046","article-title":"Evaluation of risk factors, long-term outcomes, and immediate and delayed autotransplantation to minimize postsurgical hypoparathyroidism in multiple endocrine neoplasia type 1 (MEN1): A retrospective cohort study","volume":"171","author":"Landry","year":"2022","journal-title":"Surgery"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Yavropoulou, M.P., Vlachou, S., Tsoli, M., Fostira, F., Kaltsas, G., and Kassi, E. (2022). Management and Long-Term Follow-Up of Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1: Single Center Experience. J. Clin. Med., 11.","DOI":"10.1530\/endoabs.81.P641"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Marini, F., Giusti, F., Cioppi, F., Maraghelli, D., Cavalli, T., Tonelli, F., and Brandi, M.L. (2021). Bone and Mineral Metabolism Phenotypes in MEN1-Related and Sporadic Primary Hyperparathyroidism, before and after Parathyroidectomy. Cells, 10.","DOI":"10.3390\/cells10081895"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e27098","DOI":"10.1097\/MD.0000000000027098","article-title":"Parathyroid disorder and concomitant thyroid cancer in patients with multiple endocrine neoplasia type 1: A retrospective cohort study","volume":"100","author":"Wang","year":"2021","journal-title":"Medicine"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Choi, H.R., Choi, S.H., Choi, S.M., Kim, J.K., Lee, C.R., Kang, S.W., Lee, J., Jeong, J.J., Nam, K.H., and Chung, W.Y. (2020). Benefit of diverse surgical approach on short-term outcomes of MEN1-related hyperparathyroidism. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-67424-5"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1007\/s00268-020-05695-9","article-title":"18F-fluorocholine PET\/CT in MEN1 Patients with Primary Hyperparathyroidism","volume":"44","author":"Delbot","year":"2020","journal-title":"World J. Surg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/cen.14112","article-title":"Single gland excision for MEN1-associated primary hyperparathyroidism","volume":"92","author":"Manoharan","year":"2020","journal-title":"Clin. Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Song, A., Yang, Y., Liu, S., Nie, M., Jiang, Y., Li, M., Xia, W., Wang, O., and Xing, X. (2020). Prevalence of Parathyroid Carcinoma and Atypical Parathyroid Neoplasms in 153 Patients With Multiple Endocrine Neoplasia Type 1: Case Series and Literature Review. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.557050"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00198-019-05186-1","article-title":"Impaired geometry, volumetric density, and microstructure of cortical and trabecular bone assessed by HR-pQCT in both sporadic and MEN1-related primary hyperparathyroidism","volume":"31","author":"Wang","year":"2020","journal-title":"Osteoporos. Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/PAP.0000000000000379","article-title":"Advances and Updates in Parathyroid Pathology","volume":"30","author":"Gokozan","year":"2023","journal-title":"Adv. Anat. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO Classification of Parathyroid Tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr. Pathol."},{"key":"ref_44","first-page":"68","article-title":"Parathyroid tumors in the 5th edition of the WHO Classification of Tumors of the Endocrine Organs","volume":"60","year":"2024","journal-title":"Cesk Patol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Brunetti, A., Cosso, R., Vescini, F., and Falchetti, A. (2024). Molecular Pathophysiology of Parathyroid Tumorigenesis-The Lesson from a Rare Disease: The \u201cMEN1 Model\u201d. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202409.2400.v1"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1055\/a-1132-6223","article-title":"Clinical and Molecular Genetics of Primary Hyperparathyroidism","volume":"52","author":"Simonds","year":"2020","journal-title":"Horm. Metab. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.beem.2018.09.011","article-title":"Genetics of parathyroids disorders: Overview","volume":"32","author":"Alberto","year":"2018","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jc.2014-3659","article-title":"MEN1 disease occurring before 21 years old: A 160-patient cohort study from the Groupe d\u2019\u00e9tude des Tumeurs Endocrines","volume":"100","author":"Goudet","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kamilaris, C.D.C., and Stratakis, C.A. (2019). Multiple Endocrine Neoplasia Type 1 (MEN1): An Update and the Significance of Early Genetic and Clinical Diagnosis. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00339"},{"key":"ref_50","first-page":"64","article-title":"Chronic autoimmune thyroiditis and obesity","volume":"53","author":"Valea","year":"2018","journal-title":"Arch. Balk. Med. Union."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1590\/2359-3997000000306","article-title":"Thyroid disorders in obese patients. Does insulin resistance make a difference?","volume":"61","author":"Leach","year":"2017","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"bvac001","DOI":"10.1210\/jendso\/bvac001","article-title":"MEN1 Surveillance Guidelines: Time to (Re)Think?","volume":"6","author":"Newey","year":"2022","journal-title":"J Endocr Soc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/cen.14727","article-title":"Update on the clinical management of multiple endocrine neoplasia type 1","volume":"97","author":"Pieterman","year":"2022","journal-title":"Clin. Endocrinol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","article-title":"Clinical aspects of multiple endocrine neoplasia type 1","volume":"17","author":"Cadiot","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.surg.2020.08.021","article-title":"Optimal extent of initial parathyroid resection in patients with multiple endocrine neoplasia syndrome type 1: A meta-analysis","volume":"169","author":"Nastos","year":"2021","journal-title":"Surgery"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Nobecourt, P.F., Zagzag, J., Asare, E.A., and Perrier, N.D. (2018). Intraoperative Decision-Making and Technical Aspects of Parathyroidectomy in Young Patients With MEN1 Related Hyperparathyroidism. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00618"},{"key":"ref_57","first-page":"47","article-title":"The Link Between Bone Osteocalcin and Energy Metabolism in a Group of Postmenopausal Women","volume":"45","author":"Dumitru","year":"2019","journal-title":"Curr. Health Sci. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"T119","DOI":"10.1530\/ERC-17-0199","article-title":"The future: Genetics advances in MEN1 therapeutic approaches and management strategies","volume":"24","author":"Agarwal","year":"2017","journal-title":"Endocr. Relat. Cancer."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","article-title":"Multiple Endocrine Neoplasia Type 1: Latest Insights","volume":"42","author":"Brandi","year":"2021","journal-title":"Endocr. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tibs.2013.05.005","article-title":"Menin: A scaffold protein that controls gene expression and cell signaling","volume":"38","author":"Matkar","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4419-1664-8_4","article-title":"Cellular functions of menin","volume":"668","author":"Hendy","year":"2009","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/JME-18-0050","article-title":"Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types","volume":"61","author":"Iyer","year":"2018","journal-title":"J. Mol. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mce.2017.05.010","article-title":"Alterations of DNA methylation in parathyroid tumors","volume":"469","author":"Guarnieri","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-4419-1664-8_8","article-title":"The role of menin in parathyroid tumorigenesis","volume":"668","author":"Davenport","year":"2009","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1530\/EJE-12-0327","article-title":"MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism","volume":"168","author":"Alvelos","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Mele, C., Mencarelli, M., Caputo, M., Mai, S., Pagano, L., Aimaretti, G., Scacchi, M., Falchetti, A., and Marzullo, P. (2020). Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.591501"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Marini, F., and Brandi, M.L. (2021). Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147352"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1530\/EC-20-0103","article-title":"Genetic background influences tumour development in heterozygous Men1 knockout mice","volume":"9","author":"Lines","year":"2020","journal-title":"Endocr. Connect."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12020-023-03440-5","article-title":"Thymoma in multiple endocrine neoplasia type 1: A case report and systematic review","volume":"82","author":"Gao","year":"2023","journal-title":"Endocrine."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Araujo-Castro, M., Pascual-Corrales, E., Molina-Cerrillo, J., Moreno Mata, N., and Alonso-Gordoa, T. (2022). Bronchial Carcinoids: From Molecular Background to Treatment Approach. Cancers, 14.","DOI":"10.3390\/cancers14030520"},{"key":"ref_72","first-page":"23","article-title":"Extra-adrenal adrenocortical cancer associated with multiple endocrine neoplasia type 1","volume":"2024","author":"Green","year":"2024","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Marini, F., Giusti, F., Tonelli, F., and Brandi, M.L. (2021). Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084041"},{"key":"ref_74","first-page":"10","article-title":"Multinodular and vacuolating neuronal tumor","volume":"128","author":"Mitrica","year":"2025","journal-title":"Rom. J. Mil. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1159\/000511791","article-title":"Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome\u2014An International Consensus Statement","volume":"111","author":"Niederle","year":"2021","journal-title":"Neuroendocrinology"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Papadopoulou-Marketou, N., Tsoli, M., Chatzellis, E., Alexandraki, K.I., and Kaltsas, G. (2024). Hereditary Syndromes Associated with Pancreatic and Lung Neuroendocrine Tumors. Cancers, 16.","DOI":"10.3390\/cancers16112075"},{"key":"ref_77","first-page":"129","article-title":"Hashimoto\u2019s thyroiditis and breast cancer: Coincidence or correlation?","volume":"51","author":"Valea","year":"2016","journal-title":"Arch. Balk. Med. Union"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"559","DOI":"10.21037\/jgo.2020.03.09","article-title":"Inherited syndromes involving pancreatic neuroendocrine tumors","volume":"11","author":"Geurts","year":"2020","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e13343","DOI":"10.1111\/jne.13343","article-title":"European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours","volume":"35","author":"Denecke","year":"2023","journal-title":"J. Neuroendocrinol."},{"key":"ref_80","first-page":"3515","article-title":"Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results from the DutchMEN Study Group","volume":"106","author":"Pieterman","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.soc.2022.10.008","article-title":"Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype\/Phenotype: Is There Any Advance on Predicting or Preventing?","volume":"32","author":"Ramamoorthy","year":"2023","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/17843286.2019.1660021","article-title":"Interplay between metabolic and thyroid parameters in obese pubertal children. Does visceral adipose tissue make the first move?","volume":"76","author":"Leach","year":"2021","journal-title":"Acta Clin. Belg."},{"key":"ref_83","first-page":"1132","article-title":"Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: A single-institution experience","volume":"134","author":"Brown","year":"2020","journal-title":"J. Neurosurg."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1530\/EJE-21-0630","article-title":"Pituitary adenoma in patients with multiple endocrine neoplasia type 1: A cohort study","volume":"185","author":"Leclerc","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3892\/etm.2023.12054","article-title":"Therapeutic management of atypical antipsychotic-related metabolic dysfunctions using GLP-1 receptor agonists: A systematic review","volume":"26","author":"Vasiliu","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"101978","DOI":"10.1016\/j.beem.2025.101978","article-title":"Association of primary hyperparathyroidism with pituitary adenoma and management issues","volume":"39","author":"Das","year":"2025","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_87","first-page":"78","article-title":"Gender-Dependent Associations Between Digit Ratio and Genetic Polymorphisms, BMI, and Reproductive Factors","volume":"128","author":"Nica","year":"2025","journal-title":"Rom. J. Mil. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10689-025-00440-4","article-title":"Progress report on multiple endocrine neoplasia type 1","volume":"24","author":"Halperin","year":"2025","journal-title":"Fam. Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Pierotti, L., Pardi, E., Dinoi, E., Piaggi, P., Borsari, S., Della Valentina, S., Sardella, C., Michelucci, A., Caligo, M.A., and Bogazzi, F. (2023). Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1191040"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11154-016-9401-0","article-title":"Hereditary syndromes predisposing to endocrine tumors and their skin manifestations","volume":"17","author":"Stratakis","year":"2016","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Waguespack, S.G. (2022). Beyond the \u201c3 Ps\u201d: A critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1029041"},{"key":"ref_92","first-page":"19-0040","article-title":"Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1","volume":"2019","author":"Jhawar","year":"2019","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s40618-020-01414-2","article-title":"Uncommon tumors in multiple endocrine neoplasia (MEN) type 1: Do they have a relationship with the prognosis of these patients?","volume":"44","author":"Febrero","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"318","DOI":"10.12680\/balneo.2021.457","article-title":"The importance of association between sex steroids deficiency, reduction of bone mineral density and falling risk in men with implications in medical rehabilitation","volume":"12","author":"Popa","year":"2021","journal-title":"Balneo PRM Res. J."},{"key":"ref_95","first-page":"S435","article-title":"Bone mineral density and vitamin D levels in patients with rheumatoid arthritis","volume":"28","author":"Anghel","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Rusu, C.C., Kacso, I., Moldovan, D., Potra, A., Tirinescu, D., Ticala, M., Rotar, A.M., Orasan, R., Budurea, C., and Barar, A. (2023). Triiodothyronine and Protein Malnutrition Could Influence Pulse Wave Velocity in Pre-Dialysis Chronic Kidney Disease Patients. Diagnostics, 13.","DOI":"10.3390\/diagnostics13142462"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/jbmr.4682","article-title":"Management of Primary Hyperparathyroidism","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00198-021-05822-9","article-title":"Risk of fractures in primary hyperparathyroidism: A systematic review and meta-analysis","volume":"32","author":"Rolighed","year":"2021","journal-title":"Osteoporos. Int."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e10482","DOI":"10.1002\/jbm4.10482","article-title":"The Risk of Fractures in Primary Hyperparathyroidism: A Meta-Analysis","volume":"5","author":"Narayanan","year":"2021","journal-title":"JBMR Plus"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00198-022-06629-y","article-title":"Primary hyperparathyroidism and fracture probability","volume":"34","author":"Kanis","year":"2023","journal-title":"Osteoporos. Int."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"116272","DOI":"10.1016\/j.amjsurg.2025.116272","article-title":"Patients with normocalcemic versus hypercalcemic hyperparathyroidism: What\u2019s really the difference?","volume":"244","author":"Balachandra","year":"2025","journal-title":"Am. J. Surg."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12020-024-03768-6","article-title":"Biochemical characteristics and clinical manifestation of normocalcemic primary hyperparathyroidism","volume":"85","author":"Yankova","year":"2024","journal-title":"Endocrine"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Rusu, C.C., Anton, F., Valea, A., and Bondor, C.I. (2024). N-Terminal Pro-Brain Natriuretic Peptide Correlates with Ghrelin and Acyl-Ghrelin in Pre-Dialysis Chronic Kidney Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115696"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"496","DOI":"10.12680\/balneo.2022.496","article-title":"Medical management and rehabilitation in posttraumatic common peroneal nerve palsy","volume":"13","author":"Popa","year":"2022","journal-title":"Balneo PRM Res. J."},{"key":"ref_105","first-page":"S3","article-title":"Parathyroid Hormone-Related Changes of Bone Structure","volume":"70","author":"Jackuliak","year":"2021","journal-title":"Physiol Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11657-023-01304-z","article-title":"Mortality following fragility hip fracture in China: A record linkage study","volume":"18","author":"Hua","year":"2023","journal-title":"Arch. Osteoporos."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Schaffler-Schaden, D., Schweighofer-Zwink, G., Hehenwarter, L., van der Zee-Neuen, A., Flamm, M., Beheshti, M., and Pirich, C. (2024). Bone Mineral Density and First Line Imaging with [(18)F]fluorocholine PET\/CT in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism: Results from a Single Center. Diagnostics, 14.","DOI":"10.3390\/diagnostics14222466"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.090304","article-title":"Sporadic and MEN1-related primary hyperparathyroidism: Differences in clinical expression and severity","volume":"24","author":"Chiodini","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Kong, J., Wang, O., Nie, M., Shi, J., Hu, Y., Jiang, Y., Li, M., Xia, W., Meng, X., and Xing, X. (2016). Clinical and Genetic Analysis of Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism in Chinese. PLoS ONE, 11.","DOI":"10.1530\/boneabs.5.P445"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00774-024-01561-z","article-title":"Influence of disease activity and gonadal status on bone mineral density and turnover in acromegaly","volume":"43","author":"Silva","year":"2024","journal-title":"J. Bone Miner. Metab."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s11102-024-01447-3","article-title":"Skeletal fragility in pituitary disease: How can we predict fracture risk?","volume":"27","author":"Bioletto","year":"2024","journal-title":"Pituitary"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e210494","DOI":"10.1530\/EC-21-0494","article-title":"The role of menin in bone pathology","volume":"11","author":"Gorbacheva","year":"2022","journal-title":"Endocr. Connect."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tem.2023.01.006","article-title":"New tools for bone health assessment in secreting pituitary adenomas","volume":"34","author":"Uygur","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e2843","DOI":"10.1210\/clinem\/dgac183","article-title":"High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly","volume":"107","author":"Frara","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s12020-024-03784-6","article-title":"New insights into the vitamin D\/PTH axis in endocrine-driven metabolic bone diseases","volume":"85","author":"Bilezikian","year":"2024","journal-title":"Endocrine"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Yun, S.J., Sang, H., Park, S.Y., and Chin, S.O. (2024). Effect of Hyperprolactinemia on Bone Metabolism: Focusing on Osteopenia\/Osteoporosis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031474"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s11102-020-01041-3","article-title":"Hyperprolactinemia and bone","volume":"23","author":"Doga","year":"2020","journal-title":"Pituitary"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"E1216","DOI":"10.1152\/ajpendo.2000.279.6.E1216","article-title":"Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat","volume":"279","author":"Coss","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bone.2007.11.008","article-title":"Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand\/osteoprotegerin ratio","volume":"42","author":"Seriwatanachai","year":"2008","journal-title":"Bone"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing\u2019s disease: A guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2282183","DOI":"10.1080\/07853890.2023.2282183","article-title":"High prevalence of vertebral fractures associated with preoperative cortisol levels in patients with recent diagnosis of Cushing disease","volume":"55","author":"Sun","year":"2023","journal-title":"Ann. Med."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Barber, T.M., Kyrou, I., Kaltsas, G., Grossman, A.B., Randeva, H.S., and Weickert, M.O. (2021). Mechanisms of Central Hypogonadism. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158217"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11154-019-09530-y","article-title":"Fertility issues in aggressive pituitary tumors","volume":"21","author":"Marques","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.maturitas.2020.05.004","article-title":"How to manage osteoporosis before the age of 50","volume":"138","author":"Rozenberg","year":"2020","journal-title":"Maturitas"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Cheng, C.H., Chen, L.R., and Chen, K.H. (2022). Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031376"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"4602129","DOI":"10.1155\/2017\/4602129","article-title":"Male Hypogonadism and Osteoporosis: The Effects, Clinical Consequences, and Treatment of Testosterone Deficiency in Bone Health","volume":"2017","author":"Golds","year":"2017","journal-title":"Int. J. Endocrinol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"739","DOI":"10.20945\/2359-3997000000563","article-title":"Male osteoporosis","volume":"66","author":"Bandeira","year":"2022","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1216705","DOI":"10.3389\/fonc.2023.1216705","article-title":"Case Report: Severe osteoporosis misunderstood by bone metastasis after total gastrectomy and multiple metastasectomy","volume":"13","author":"Hwang","year":"2023","journal-title":"Front Oncol."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Altieri, B., Di Dato, C., Modica, R., Bottiglieri, F., Di Sarno, A., Pittaway, J.F.H., Martini, C., Faggiano, A., and Colao, A. (2020). Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors. Nutrients, 12.","DOI":"10.3390\/nu12041021"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00774-012-0355-3","article-title":"Menin and bone metabolism","volume":"30","author":"Kaji","year":"2012","journal-title":"J. Bone Miner. Metab."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1074\/jbc.M114.629899","article-title":"Osteoblast menin regulates bone mass in vivo","volume":"290","author":"Kanazawa","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/cdd.2016.165","article-title":"Loss of menin in osteoblast lineage affects osteocyte-osteoclast crosstalk causing osteoporosis","volume":"24","author":"Liu","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e10622","DOI":"10.1002\/jbm4.10622","article-title":"Genetic Deletion of Menin in Mouse Mesenchymal Stem Cells: An Experimental and Computational Analysis","volume":"6","author":"Asgari","year":"2022","journal-title":"JBMR Plus"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Troka, I., Griffanti, G., Canaff, L., Hendy, G.N., Goltzman, D., and Nazhat, S.N. (2022). Effect of Menin Deletion in Early Osteoblast Lineage on the Mineralization of an In Vitro 3D Osteoid-like Dense Collagen Gel Matrix. Biomimetics, 7.","DOI":"10.3390\/biomimetics7030101"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1210\/jc.2018-00259","article-title":"High Fear of Disease Occurrence Is Associated With Low Quality of Life in Patients With Multiple Endocrine Neoplasia Type 1: Results From the Dutch MEN1 Study Group","volume":"103","author":"Pieterman","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ecl.2022.04.007","article-title":"Quality of Life in Primary Hyperparathyroidism","volume":"51","author":"Cipriani","year":"2022","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12020-020-02519-7","article-title":"The influence of parathyroidectomy on cardiometabolic risk factors in patients with primary hyperparathyroidism: A systematic review and meta-analysis","volume":"72","author":"Yavari","year":"2021","journal-title":"Endocrine"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.4225","article-title":"Quality of Life in Primary Hyperparathyroidism Revisited: Keep Calm and Carry on?","volume":"36","author":"Walker","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e210630","DOI":"10.1530\/EC-21-0630","article-title":"Changes in quality of life 6 months after parathyroidectomy for primary hyperparathyroidism","volume":"11","author":"Christensen","year":"2022","journal-title":"Endocr. Connect."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"T227","DOI":"10.1530\/ERC-17-0203","article-title":"Management impact: Effects on quality of life and prognosis in MEN1","volume":"24","author":"Marini","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1002\/jbmr.4675","article-title":"Epidemiology and Financial Burden of Adult Chronic Hypoparathyroidism","volume":"37","author":"Bjornsdottir","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s40618-024-02366-7","article-title":"Familial states of primary hyperparathyroidism: An update","volume":"47","author":"Cetani","year":"2024","journal-title":"J. Endocrinol. Investig."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Blau, J.E., and Simonds, W.F. (2021). Familial Hyperparathyroidism. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.623667"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s12020-023-03497-2","article-title":"Multiple endocrine neoplasia type 4 (MEN4): A thorough update on the latest and least known men syndrome","volume":"82","author":"Ruggeri","year":"2023","journal-title":"Endocrine"},{"key":"ref_145","first-page":"e220174","article-title":"Germline CDKN1B variant type and site are associated with phenotype in MEN4","volume":"30","author":"Halperin","year":"2022","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.semcancer.2021.03.035","article-title":"Multiple endocrine neoplasia type 2: A review","volume":"79","author":"Mathiesen","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CCO.0000000000001009","article-title":"Multiple endocrine neoplasia type 2: Towards a risk-based approach integrating molecular and biomarker results","volume":"36","author":"Machens","year":"2024","journal-title":"Curr. Opin. Oncol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/EC-20-0163","article-title":"Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: An international multicenter study","volume":"9","author":"Larsen","year":"2020","journal-title":"Endocr. Connect."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/9\/3113\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:25:07Z","timestamp":1760030707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/9\/3113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":148,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["jcm14093113"],"URL":"https:\/\/doi.org\/10.3390\/jcm14093113","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]}}}